Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
852851-68-4
1782829-26-8
1782284-08-5
847837-40-5 | 2-Ethyl-4-methylquinoline-3-carboxylic acid | AA019OCZ | MFCD07323952
869634-08-2 | 1-(2-fluorophenyl)-6-methyl-4-oxo-1,4-dihydropyridazine-3-carboxylic acid | AA019OJM | MFCD07343832
873208-62-9 | 3,4-dimethyl-5-nitrobenzene-1-sulfonyl chloride | AA019OQO | MFCD07687268
956796-80-8 | 5-(2-bromophenyl)-5-methylimidazolidine-2,4-dione | AA019OYG | MFCD04620390
1049766-99-5 | 2-chloro-1-[4-(thiophen-2-ylmethyl)piperazin-1-yl]ethan-1-one hydrochloride | AA019P5C | MFCD07838434
1049604-83-2 | 2-chloro-N-[2-(diethylamino)-5-(diethylsulfamoyl)phenyl]acetamide | AA019PCF | MFCD09971330
29670-63-1 | 2-phenyl-2-(phenylformamido)acetic acid | AA019PIV | MFCD00666894
238428-28-9 | N-[2-(aminomethyl)phenyl]acetamide hydrochloride | AA019PP9 | MFCD20441551
1049760-14-6 | ethyl 2-(aminomethyl)-4-methylpentanoate hydrochloride | AA019Q4D | MFCD09836810
1087788-54-2 | 2,2,2-Trifluoroethyl 3-(trifluoromethoxy)phenylcarbamate | AA019QPI | MFCD11099782
Journal: Bioorganic & medicinal chemistry letters20101101